이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Hospital Corporation of China 미래 성장

Future 기준 확인 0/6

현재 Hospital of China 의 성장과 수익을 예측할 만큼 분석가의 범위가 충분하지 않습니다.

주요 정보

n/a

수익 성장률

n/a

EPS 성장률

Healthcare 수익 성장	17.0%
매출 성장률	n/a
향후 자기자본 수익률	n/a
애널리스트 커버리지	None
마지막 업데이트	n/a

최근 미래 성장 업데이트

Recent updates

We Think Hospital Corporation of China's (HKG:3869) Profit Is Only A Baseline For What They Can Achieve

Apr 29

Hospital Corporation of China Limited (HKG:3869) Stock Rockets 33% But Many Are Still Ignoring The Company

Jun 30

Hospital Corporation of China (HKG:3869) Hasn't Managed To Accelerate Its Returns

May 17

Does Hospital Corporation of China (HKG:3869) Have A Healthy Balance Sheet?

Apr 12

Would Shareholders Who Purchased Hospital Corporation of China's (HKG:3869) Stock Three Years Be Happy With The Share price Today?

Mar 08

Should You Be Impressed By Hospital Corporation of China's (HKG:3869) Returns on Capital?

Jan 14

Hospital Corporation of China (HKG:3869) Takes On Some Risk With Its Use Of Debt

Dec 10

이 섹션에서는 일반적으로 투자자가 회사의 수익 창출 능력을 이해하는 데 도움이 되도록 전문 애널리스트의 컨센서스 추정치를 기반으로 수익 및 수익 성장 전망치를 제시합니다. 하지만 Hospital Corporation of China 은 충분한 과거 데이터를 제공하지 않았고 애널리스트 예측도 없기 때문에 과거 데이터를 추정하거나 애널리스트 예측을 사용하여 미래 수익을 안정적으로 계산할 수 없습니다.

SimplyWall St에서 다루는 기업의 97%가 과거 재무 데이터를 가지고 있기 때문에 이는 매우 드문 상황입니다.

수익 및 매출 성장 예측

SEHK:3869 - 애널리스트의 미래 추정치 및 과거 재무 데이터 (CNY Millions )
날짜	수익	수익	잉여 현금 흐름	작전 현금	평균 애널리스트 수
12/31/2023	1,428	131	67	83	N/A
9/30/2023	1,374	102	123	137	N/A
6/30/2023	1,320	73	179	192	N/A
3/31/2023	1,231	-204	153	167	N/A
12/31/2022	1,143	-481	126	143	N/A
9/30/2022	998	-424	81	96	N/A
6/30/2022	854	-367	36	49	N/A
3/31/2022	687	-324	77	91	N/A
12/31/2021	520	-281	117	133	N/A
9/30/2021	473	-245	132	146	N/A
6/30/2021	426	-210	146	159	N/A
3/31/2021	412	-307	110	121	N/A
12/31/2020	399	-404	73	83	N/A
9/30/2020	391	-435	75	86	N/A
6/30/2020	383	-467	76	88	N/A
3/31/2020	397	-158	64	76	N/A
12/31/2019	411	151	51	63	N/A
9/30/2019	414	110	57	72	N/A
6/30/2019	418	70	62	81	N/A
3/31/2019	401	10	77	102	N/A
12/31/2018	384	-50	91	122	N/A
6/30/2018	235	-53	30	49	N/A
3/31/2018	192	-40	38	48	N/A
12/31/2017	149	-27	46	47	N/A
6/30/2017	143	-5	N/A	75	N/A
3/31/2017	137	9	N/A	120	N/A
12/31/2016	131	23	N/A	164	N/A
9/30/2016	160	34	N/A	162	N/A
12/31/2015	143	51	N/A	7	N/A
12/31/2014	28	2	N/A	4	N/A

애널리스트 미래 성장 예측

수입 대 저축률: 3869 의 예상 수익 증가율이 절약률( 2.2% )보다 높은지 판단하기에는 데이터가 부족합니다.

수익 vs 시장: 3869 의 수익이 Hong Kong 시장보다 빠르게 성장할 것으로 예상되는지 판단하기에는 데이터가 부족합니다.

고성장 수익: 3869 의 수익이 향후 3년 동안 상당히 증가할 것으로 예상되는지 판단하기에는 데이터가 부족합니다.

수익 대 시장: 3869 의 수익이 Hong Kong 시장보다 빠르게 성장할 것으로 예상되는지 판단하기에는 데이터가 부족합니다.

고성장 수익: 3869 의 수익이 연간 20% 보다 빠르게 증가할 것으로 예상되는지 판단하기에는 데이터가 부족합니다.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: 3869 의 자기자본수익률이 3년 내에 높을 것으로 예상되는지 판단하기에는 데이터가 부족합니다.

Hospital Corporation of China 미래 성장

Future 기준 확인 0/6

주요 정보

최근 미래 성장 업데이트

Hospital Corporation of China Limited Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended June 30, 2022

Recent updates

We Think Hospital Corporation of China's (HKG:3869) Profit Is Only A Baseline For What They Can Achieve

Hospital Corporation of China Limited, Annual General Meeting, Jun 20, 2024

New major risk - Financial position

Full year 2023 earnings released: EPS: CN¥0.96 (vs CN¥3.48 loss in FY 2022)

Hospital Corporation of China Limited to Report Fiscal Year 2023 Results on Mar 26, 2024

Investor sentiment deteriorates as stock falls 22%

New minor risk - Share price stability

Investor sentiment improves as stock rises 26%

First half 2023 earnings released: EPS: CN¥0.91 (vs CN¥3.09 loss in 1H 2022)

Investor sentiment improves as stock rises 23%

First half 2023 earnings released: EPS: CN¥0.91 (vs CN¥3.08 loss in 1H 2022)

Hospital Corporation of China Limited to Report Q2, 2023 Results on Aug 30, 2023

New minor risk - Market cap size

Now 36% undervalued after recent price drop

New minor risk - Share price stability

Hospital Corporation of China Limited (HKG:3869) Stock Rockets 33% But Many Are Still Ignoring The Company

Full year 2022 earnings released: CN¥3.48 loss per share (vs CN¥2.03 loss in FY 2021)

Hospital Corporation of China Limited Announces Resignation of Lu Wenzuo as Executive Director

Less than half of directors are independent

First half 2022 earnings released: CN¥3.08 loss per share (vs CN¥2.47 loss in 1H 2021)

First half 2022 earnings released: CN¥3.09 loss per share (vs CN¥2.47 loss in 1H 2021)

Hospital Corporation of China Limited to Report Q2, 2022 Results on Aug 30, 2022

Hospital Corporation of China Limited Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended June 30, 2022

Hospital Corporation of China Limited, Annual General Meeting, Jun 22, 2022

Less than half of directors are independent

Full year 2021 earnings released: CN¥2.03 loss per share (vs CN¥2.93 loss in FY 2020)

Hospital Corporation of China Limited Announces Executive Changes

First half 2021 earnings released: CN¥2.47 loss per share (vs CN¥3.87 loss in 1H 2020)

Non Executive Director Zhiqiang Su has left the company

Hospital Corporation of China (HKG:3869) Hasn't Managed To Accelerate Its Returns

Full year 2020 earnings released: CN¥2.93 loss per share (vs CN¥1.09 profit in FY 2019)

Does Hospital Corporation of China (HKG:3869) Have A Healthy Balance Sheet?

Full year 2020 earnings released: CN¥2.93 loss per share (vs CN¥1.09 profit in FY 2019)

Hospital Corporation of China Limited to Report Fiscal Year 2020 Results on Mar 30, 2021

Would Shareholders Who Purchased Hospital Corporation of China's (HKG:3869) Stock Three Years Be Happy With The Share price Today?

New 90-day high: HK$11.38

Hospital Corporation of China Limited Announces Executive Changes

Should You Be Impressed By Hospital Corporation of China's (HKG:3869) Returns on Capital?

New 90-day low: HK$10.60

New 90-day low: HK$10.90

Hospital Corporation of China (HKG:3869) Takes On Some Risk With Its Use Of Debt

Hospital Corporation of China Limited Announces Management Changes

First half earnings released

Hospital Corporation of China Limited to Report First Half, 2020 Results on Aug 28, 2020

수익 및 매출 성장 예측

애널리스트 미래 성장 예측

주당 순이익 성장 예측

미래 자기자본 수익률

성장 기업 발견